Clinical trial
Mesothelin as a New Tumor Marker for Ovarian Cancer
NCT00155740 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mesothelin as a New Tumor Marker for Ovarian Cancer
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2002
- Completion date
- December 31, 2006
- Enrollment
- 250
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer